< News Archive >
*** August 16, 2016: We are very happy to announce that the Research Collaborative Agreement (RCA) between MultiCASE Inc and US FDA's Center for Drug Evaluation and Research (CDER) has been extended for another 5 years till July 2021. The title of the RCA project is Enhancement of In Silico Decision Support Tools for the Evaluation of Drug Safety. We are looking forward for a lot of productive research and exciting innovations with CDER in this duration.
MultiCASE attended the 17th International Conference on QSAR in Environmental and Health Sciences, June 13–17, 2016, Miami, FL, USA.
MultiCASE attended the Society of Toxicology 55th Annual Meeting and ToxExpo, March 13–17, 2016.
Poster: CASE Ultra Konsolidator: A Knowledge Driven Algorithm to Assist in Expert Review of ICH M7 Based (Q)SAR Analysis of Bacterial Mutagenicity of Impurities.
10/6/2015: MultiCASE attended Annual Meeting of American College of Toxicology November 8-11, 2015, Red Rock Resort, Summerlin, Nevada, US.
10/7/2015: MultiCASE Users' Meeting in Japan took place on October 6, 2015 in Tokyo.
10/5/2015: MultiCASE attended 3rd Annual FDA Scientific Computing Day, Washington DC, USA, September 9, 2015.
3/23/2015: MultiCASE hosted an exhibitor session “In Silico approach to the ICH M7 challenges” and several poster presentations (abstracts #1313, #2210, and #2211) at SOT 2015 Annual Meeting in San Diego.
1/23/2015: We released a fully featured Expert Rule based system for mutagenicity prediction in addition to new statistical models for E. coli and Salmonella mutagenicity.
11/28/2014: MultiCASE was a Gold Sponsor in the Elemental and Genotoxic Impurities Conference held at Hyatt Regency, Mumbai, India, 26-28 November 2014. We gave a platform talk on Alert Based QSARs.
9/19/2014: MultiCASE attended the American College of Toxicology’s 35th Annual Meeting from November 9–12, 2014, at the Hyatt Regency Grand Cypress in Orlando, Florida. It was a great experience in terms of meeting with great people and sharing and learning about progress being made at the frontier of toxicology research.
9/18/2014: MultiCASE attended the 2nd Annual FDA Scientific Computing Day at the FDA White Oak Campus in Silver Spring, Maryland.
7/22/2014: MultiCASE attended the Eurotox Meeting at Edinburgh, from 7th to 10th September 2014.
We presented a poster titled “An improved workflow to perform in silico mutagenicity assessment of impurities as per ICH M7 guideline”.
5/6/2015: MultiCASE attended GTA 2015 Annual Meeting in Newark, Delaware.
10/5/2015: MultiCASE attended 51st Annual Congress of the European Societies of Toxicology, Porto, Portugal, September 13-16, 2015, had an Exhibitor Booth and poster presentation.